Discussion about this post

User's avatar
Stock Lens's avatar

Piramal Pharma is not a one-trick story. It combines:

A trusted partner for pharma companies making complex, high-value drugs,

A global leader in critical hospital medicines, and

A recognizable consumer healthcare brand house in India.

The company faces near-term bumps, but with world-class compliance, global scale, and investments in next-gen therapies, it has a credible shot at achieving its FY2030 vision.

For investors, that could mean meaningful upside if execution stays on track.

https://stocklens.substack.com/p/piramal-pharma-a-global-three-in

Expand full comment

No posts